Output details
4 - Psychology, Psychiatry and Neuroscience
Imperial College London
Article title
(11)C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Type
D - Journal article
Title of journal
Lancet Neurology
Article number
-
Volume number
9
Issue number
4
First page of article
363
ISSN of journal
1474-4422
Year of publication
2010
URL
-
Number of additional authors
16
Additional information
The author made a substantial contribution to the conception and design of the study and to analysis and interpretation of study data.
The author helped critique the output for important intellectual content.
Interdisciplinary
-
Cross-referral requested
-
Research group
A - Neuroinflammation and Neurodegeneration
Citation count
252
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-
